申请人:Teleos Therapeutics, LLC
公开号:US20180161310A1
公开(公告)日:2018-06-14
Compounds that inhibit synaptic hyperexcitability, pharmaceutical compositions of these compounds, and methods of using the compounds and pharmaceutical compositions thereof to treat diseases and/or disorders such as epilepsy, neuropathic pain, spinal cord injury spasticity, morphine-induced hyperalgesia, schizophrenia, and autism spectrum disorders are disclosed. In some embodiments, the compounds have the general structure of Formula 1 or Formula 2: